Pivot Bio Patents – Insights & Stats (Updated 2023)

Pivot Bio has a total of 340 patents globally, out of which 42 have been granted. Of these 340 patents, more than 88% patents are active. The USA is where Pivot Bio has filed the maximum number of patents, followed by Europe (EPO) and Canada. Parallelly, the USA seems to be the main focused R&D centre of Pivot Bio and is also the origin country of the firm.

Pivot Bio was founded in the year 2011 by Alvin Tamsir and Karsten Temme. The company is an agricultural tech company improving the microbiome by taking nitrogen from the air and making it available for plants.

Do read about some of the most popular patents of Pivot Bio which have been covered by us in this article and also you can find Pivot Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pivot Bio patent portfolio.

How many patents does Pivot Bio have?

Pivot Bio has a total of 340 patents globally. These patents belong to 69 unique patent families. Out of 340 patents, 302 patents are active.

How Many Patents did Pivot Bio File Every Year?

Pivot Bio Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantPivot Bio Applications FiledPivot Bio Patents Granted
20222011
2021819
2020805
2019672
2018601
20171
201619
2015
2014
20132
2012
2011

How many Pivot Bio patents are Alive/Dead?

Worldwide Patents

Pivot Bio Patent Portfolio

How Many Patents did Pivot Bio File in Different Countries?

Pivot Bio Worldwide Patent Filing

List of Countries in which Pivot Bio Filed Patents

CountryPatents
United States Of America31
Europe22
Canada22
Brazil21
Argentina19
Australia18
India18
Mexico17
South Africa16
Japan14
Africa14
Russia13
Korea (South)13
Hong Kong (S.A.R.)12
Indonesia11
Viet Nam10
Philippines9
Uruguay8
Paraguay7
Pakistan6
China3
Bangladesh2
Kenya1
Singapore1
Turkey1

Where are Research Centres of Pivot Bio Patents Located?

R&D Centres of Pivot Bio

10 Best Pivot Bio Patents

US20140038240A1 is the most popular patent in the Pivot Bio portfolio. It has received 47 citations so far from companies like Twist Bioscience Corporation.

Below is the list of 10 most cited patents of Pivot Bio:

Publication NumberCitation Count
US20140038240A147
WO2018132774A146
WO2017011602A126
WO2014011800A125
WO2019032926A124
WO2019084342A119
US20190039964A118
US9975817B217
WO2020006246A116
WO2020014498A116

What are Pivot Bio‘s key innovation segments?

What Technologies are Covered by Pivot Bio?

The chart below distributes patents filed by Pivot Bio in different countries on the basis of the technology protected in patents. It also represents the markets where Pivot Bio thinks it’s important to protect particular technology inventions.

R&D Focus: How has Pivot Bio search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Pivot Bio?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.